Matches in Wikidata for { <http://www.wikidata.org/entity/Q65546741> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q65546741 description "clinical trial" @default.
- Q65546741 description "ensayu clínicu" @default.
- Q65546741 description "klinisch onderzoek" @default.
- Q65546741 description "клінічне випробування" @default.
- Q65546741 description "կլինիկական փորձարկում" @default.
- Q65546741 name "A Trial of Doxorubicin/Cyclophosphamide (AC), Docetaxel (D), and Alternating AC and D for Metastatic Breast Cancer" @default.
- Q65546741 name "A Trial of Doxorubicin/Cyclophosphamide (AC), Docetaxel (D), and Alternating AC and D for Metastatic Breast Cancer" @default.
- Q65546741 type Item @default.
- Q65546741 label "A Trial of Doxorubicin/Cyclophosphamide (AC), Docetaxel (D), and Alternating AC and D for Metastatic Breast Cancer" @default.
- Q65546741 label "A Trial of Doxorubicin/Cyclophosphamide (AC), Docetaxel (D), and Alternating AC and D for Metastatic Breast Cancer" @default.
- Q65546741 prefLabel "A Trial of Doxorubicin/Cyclophosphamide (AC), Docetaxel (D), and Alternating AC and D for Metastatic Breast Cancer" @default.
- Q65546741 prefLabel "A Trial of Doxorubicin/Cyclophosphamide (AC), Docetaxel (D), and Alternating AC and D for Metastatic Breast Cancer" @default.
- Q65546741 P1132 Q65546741-56491745-6768-44F4-A63D-4C77288DE3D4 @default.
- Q65546741 P1476 Q65546741-F76AE4C1-EFED-4800-8D10-3B683DB343FF @default.
- Q65546741 P17 Q65546741-6C84ED3E-9A98-4337-A4EB-4D6CD1CE453C @default.
- Q65546741 P2899 Q65546741-7CFEA4C5-9EAF-4E2E-BF16-79467811F2D9 @default.
- Q65546741 P3098 Q65546741-6F155613-5393-4D81-920A-32DD8BB43D09 @default.
- Q65546741 P31 Q65546741-20A8E521-0C58-4993-952A-98028C6FF18C @default.
- Q65546741 P4135 Q65546741-FA892A84-CD8E-4141-8706-56257089E900 @default.
- Q65546741 P4844 Q65546741-2C0665A2-BFF4-4D86-AFEA-791B60FD1DAE @default.
- Q65546741 P4844 Q65546741-D11024D9-37AA-4337-A8D1-0351B9E58AE9 @default.
- Q65546741 P4844 Q65546741-FA61EB41-2946-4396-89F8-55AAB273068E @default.
- Q65546741 P580 Q65546741-0306CE3E-6B9C-44AF-A416-9A90D07B8537 @default.
- Q65546741 P582 Q65546741-09AFC86A-00A2-45CE-B083-6012307E3FC6 @default.
- Q65546741 P6099 Q65546741-90F6CAD3-2A94-472C-8D36-F1951A70FCCA @default.
- Q65546741 P6153 Q65546741-D458924B-EB10-435A-87B7-83476C0E85C2 @default.
- Q65546741 P8363 Q65546741-B7C50334-BEF9-4025-8271-B260711C8C28 @default.
- Q65546741 P1132 "+450" @default.
- Q65546741 P1476 "Phase III Trial of Doxorubicin /Cyclophosphamide (AC), Docetaxel (D), and Alternating AC and D (AC-D) as Front-line Chemotherapy for Metastatic Breast Cancer: Japan Clinical Oncology Group Trial (JCOG9802)" @default.
- Q65546741 P17 Q17 @default.
- Q65546741 P2899 "+20" @default.
- Q65546741 P3098 "NCT00190489" @default.
- Q65546741 P31 Q30612 @default.
- Q65546741 P4135 "+75" @default.
- Q65546741 P4844 Q18936 @default.
- Q65546741 P4844 Q29004943 @default.
- Q65546741 P4844 Q408524 @default.
- Q65546741 P580 "1999-01-01T00:00:00Z" @default.
- Q65546741 P582 "2006-05-01T00:00:00Z" @default.
- Q65546741 P6099 Q42824827 @default.
- Q65546741 P6153 Q55454195 @default.
- Q65546741 P8363 Q78089383 @default.